tradmap

MEDP Medpace Holdings, Inc.

$593.43 +0.09%

Updated

Industrials · Services-Commercial Physical & Biological Research

Medpace Holdings, Inc. (MEDP) is a industrials company in the Services-Commercial Physical & Biological Research industry, with a market capitalization of $16.6 billion. Shares last traded at $593.43, 12.5% below their 52-week high. Over the past year the stock is up 23.4%. MEDP trades at a price-to-earnings ratio of 33.70, above the Services-Commercial Physical & Biological Research median of 33.22. Net profit margin is 17.7%, above the peer median of 8.3%. Revenue grew 20.0% year over year.

Market Cap
$16.6B
Shares Out
27.9M
EPS (TTM)
$30.24
P/E Ratio
19.62
P/S Ratio
5.95
P/B Ratio
38.18
Dividend / Share
Dividend Yield
52-Week High
$677.90
52-Week Low
$375.00
Volume
6,783
Avg Vol (3m)
19,861.794

Performance

1W
-2.93%
1M
+0.91%
3M
+29.45%
6M
+26.48%
YTD
+3.99%
1Y
+23.41%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
51.25
SMA (50)
$574.33
SMA (200)
$520.73
Price vs SMA50
+3.33%
Price vs SMA200
+13.96%
ATR (14)
$18.14

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$2.8B
Net Income
$492M
Gross Margin
Operating Margin
21.0%
Net Margin
17.7%
Return on Equity
113.3%
Return on Assets
23.9%
Current Ratio
0.73
Debt / Equity
0.00
Revenue Growth (YoY)
+20.0%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $8.53 2026-07-23
Q1 2026 $4.28 2026-04-23
FY 2025 $15.28 2026-02-10
Q3 2025 $10.64 2025-10-23
Q2 2026 $6.79 2026-07-23
Q1 2026 $3.67 2026-04-23

Full earnings history →

Services-Commercial Physical & Biological Research peers

MEDP vs 14 industry peers (Services-Commercial Physical & Biological Research), by market cap. Updated

P/E vs peers
33.70 / 33.22 med
+1% premium
P/S vs peers
5.95 / 4.14 med
+44% premium
Net margin vs peers
17.7% / 8.3% med
above median
1–14 of 14
IQVIQVIA$45.3B32.742.738.3%+2.95%
INCYIncyte$25.6B17.864.7726.7%-0.68%
MEDPMedpace Holdings, Inc.$16.6B33.705.9517.7%+0.09%
CRLCharles River Laboratories$14.0B-58.723.50-6.0%+0.54%
ABSIAbsci Corp$1.5B-12.46332.71-0.06%
OABIOmniAb, Inc.$689M-15.57-5.77%
NRCNrc Health$470M40.513.368.3%+6.23%
MXCTMAXCYTE, INC.$131M-3.66-1.17%
BIAFbioAffinity Technologies, Inc.$100M-6.60+22.48%
ONMDOneMedNet Corp$35M-4.15+4.13%
ISPCiSpecimen Inc.$4M-0.34+4.70%
IBACRIB Acquisition Corp.$580955-1.45+0.87%
ICLRIcon Plc2.1%+2.36%
BIAFWbioAffinity Technologies, Inc.+80.18%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.